September 22, 2023
Osteoarthritis isn’t a typical target for startups but Moximed isn’t developing a typical device. In this episode, CEO Anton Clifford will walk us through...
01:00:44
February 09, 2024
In this week’s episode, Procyrion CEO Eric Fain details the next steps for the startup’s ambitious plans to secure FDA approval for Aortix, a...
00:54:28
July 25, 2023
In the newest episode of AbbottTalks, Allen Burton, Divisional VP and Chief Medical Officer of Neuromodulation at Abbott, shares insights into the company's innovative...
00:59:37